Bio-Techne Corporation (TECH) Financials

TECH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.6 billion 465.3 million
Dec. 31, 2025 2.5 billion 511.7 million
Sept. 30, 2025 2.5 billion 560.3 million
June 30, 2025 2.6 billion 639.1 million

TECH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 77.6 million 10.5 million
Dec. 31, 2025 76.5 million 14.0 million
Sept. 30, 2025 22.2 million 11.7 million
June 30, 2025 93.3 million 4.6 million

TECH Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 51.0 million
Dec. 31, 2025 38.0 million
Sept. 30, 2025 38.2 million
June 30, 2025 -17.7 million

TECH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 209.8 million 200.0 million 76.1 million
Dec. 31, 2025 172.9 million 260.0 million 90.9 million
Sept. 30, 2025 145.0 million 300.0 million 94.5 million
June 30, 2025 162.2 million 346.0 million 98.1 million

TECH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 156.9 million
Dec. 31, 2025 157.0 million
Sept. 30, 2025 156.4 million
June 30, 2025 155.8 million

TECH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 9.1 million 23.5 million 109.3 million -
Dec. 31, 2025 5.9 million 23.1 million 113.7 million -
Sept. 30, 2025 5.4 million 24.2 million 116.2 million -
June 30, 2025 4.9 million 26.0 million 23.2 million -

TECH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 311.4 million 103.1 million
Dec. 31, 2025 295.9 million 104.6 million
Sept. 30, 2025 286.6 million 98.4 million
June 30, 2025 317.0 million 118.2 million

TECH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TECH

Price: $50.85

52 week price:
43.31
72.16

Dividend Yield: 0.66%

5-year range yield:
0.26%
1.51%

Forward Dividend Yield: 0.64%

Payout Ratio: 30.48%

Payout Ratio Range:
-70.07%
189.12%

Dividend Per Share: 0.32 USD

Earnings Per Share: 0.70 USD

P/E Ratio: 67.74

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 837800

Ebitda: 39.7 million

Market Capitalization: 7.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 19

DGR3: 16.67%

DGR5: 10.00%

DGR10: 5.08%

Links: